BioMarin

In News

Does VOXZOGO’s Hypochondroplasia Phase 3 Success Change The Bull Case For BioMarin (BMRN)? - simplywall.st

simplywall.st - Jun 02, 2026

Kim Warner Builds Pathways for Early-Career Professionals | BioMarin - BioMarin Pharmaceutical

BioMarin Pharmaceutical - May 29, 2026

BioMarin Pharmaceutical Inc. (BMRN) A Stock that Could 10x by 2030 on Pipeline Development - Yahoo Finance

Yahoo Finance - May 30, 2026

With Voxzogo under pressure, BioMarin touts trial win in label expansion bid - Fierce Pharma

Fierce Pharma - May 21, 2026

BioMarin’s $270M Inozyme bet looks in trouble after rare disease drug misses key ph. 3 goal - Fierce Biotech

Fierce Biotech - May 18, 2026

BioMarin suffers another blow to rare disease portfolio in Phase 3 flop - BioSpace

BioSpace - May 19, 2026

This Week’s Biopharma News: New Approvals, Appeals, and AI - The Medicine Maker

The Medicine Maker - Jun 02, 2026

BioMarin Announces Board Leadership Transition - PR Newswire

PR Newswire - Apr 21, 2026

BioMarin moves to expand Voxzogo into hypochondroplasia with pivotal win - FirstWord Pharma

FirstWord Pharma - May 20, 2026

Why Do I Pheel This Way? New Video Podcast Series Sheds Light on Navigating Adolescence with Phenylketonuria - BioMarin Pharmaceutical

BioMarin Pharmaceutical - May 28, 2026

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today - Yahoo Finance

Yahoo Finance - May 22, 2026

BioMarin Completes Acquisition of Amicus Therapeutics - PR Newswire

PR Newswire - Apr 27, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment